We report the first case of an HCV-positive recipient who was transplanted with an HCV-positive graft with portal-portal bridging fibrosis. Curbing HCV infection immediately after liver transplant with direct-acting antivirals, resulted in an excellent 9-month outcome. This article is protected by copyright. All rights reserved.
Favorable short-term outcome of hepatitis C virus–positive liver graft with bridging fibrosis: A plea for very early viral eradication
SALIZZONI, Mauro;Tandoi, Francesco;FONIO, Paolo;SARACCO, Giorgio Maria;ROMAGNOLI, Renato
Last
2017-01-01
Abstract
We report the first case of an HCV-positive recipient who was transplanted with an HCV-positive graft with portal-portal bridging fibrosis. Curbing HCV infection immediately after liver transplant with direct-acting antivirals, resulted in an excellent 9-month outcome. This article is protected by copyright. All rights reserved.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
HEP-16-1786.R1.pdf
Accesso aperto
Descrizione: Articolo principale
Tipo di file:
PREPRINT (PRIMA BOZZA)
Dimensione
386.22 kB
Formato
Adobe PDF
|
386.22 kB | Adobe PDF | Visualizza/Apri |
|
Martini_et_al-2017-Hepatology.pdf
Accesso riservato
Descrizione: Articolo principale
Tipo di file:
PDF EDITORIALE
Dimensione
271.96 kB
Formato
Adobe PDF
|
271.96 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
PDF3.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
269.55 kB
Formato
Adobe PDF
|
269.55 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
